










Life-threateningventriculararrhythmiascharacterizethe ovett phase of
ARVC;indeedsuddendeathamongyoungpeoplemaybe the first clini-
calmanifestationof thedisease.Thus,the moatimportantclinicalchallenge
is the early recognitionof the concealedphase,in whichpatientsmaybe
asymptomaticand consideredcompletelynormal.Toassessthe incidence




ing and ECHOexaminationwererepeatadeveryfour monthsduringthe
follow-upinallfamilymembers.SubjectswhodevelopedARVCweretreated
withempiricantiarrhythmicdrugsandlimitedin theirsperlactivity.Seventy
fourof 216atudysubjects(34%)hadRVCand40 of the74 (54%)showed
progressiveinvolvementof the rightventricleduringa meanfollow-upof 66
+44 months.The6-yearsactuarialprobabilityof the asymptomaticpeople
withRVCtodevelopventriculararrhythmiaswaasignificantlyhigherthanthat
of familymemberswithoutechofindingasuggestiveof RVDat intakeinto
the study(90+ 14%VS3+ 0.7%,P < O.COI).NodeathsoccurTeduring
thefollow-up.Corrc/usions:2DECHOisableto recognizeasymptomaticrel-
ativeeof patientswithARVCat highriskto developventriculararrhythmias;







Mutationof the CTGntrinucksotidarepeatregionin the myotoninkinaae










A bimodaldistributionof theCTGrepeatallelein bothpatientandcontrol
groupswas obaerved.A significantdifferencewas identifiedbetweenthe
fkatpaake.Thepropo~ionof patientaIntheDCMgroupwith5 CTGrepeats
(24%)waasignificantlylessthan in the controlgroup(34%):p c 0.05.No
differencewasfoundon examinationof DNAextractedfromvenousblood,
andthatextractedfromendomyocardialbiopsytissue.
Furthermore,1 patientwas identifiedas havinga CTGnmutationcor-
respondingto between600-900 repeats.This patientdid not haveextra-
cardiacfeatureaof myotonicdystrophyat thetimeof primaiyevaluation.
Thesefindingssuggesta rolefor the myotoninkinasegenein idiopathic
dilatedcardiomyopathy.
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sufta:Frequencydistributioncurveswereplottedand showeda shift to the
rightin theasymptomaticrelativesascomparedto thecontrolgroupfor the















0 s 10~ 15 k i
Mitralplane(mm) Papillaryplane (mm)
patients control patients control
Ant, septum 10.7* 3.9 7.7* t,z 10.3* 4,1 7.e+ 1.2
Post.septum 10.3 + 3.3* 8.1 + 1.4 10.5* 3.3 8.6* 1.4
Post wall 10.0+2.9” S.1 * 1.2 10.3* 3.3 S,4* 1.7
Lat. wall 10.3* 4. I** S.2+C1.2 10,O* 1.8* S.7 * 1.7
(*P < 0.05 VS.control,**p< 0.01 vs. control)
Conclusion.’Inaaymptomaticbutgeneticallyaffectedmembersofafamily
witha newmutationon exon27 in the hinge region of the ~-myoain gene a
slightbutsignificantincreaseinIeftventricularwallthicknesaanda rightward
shiftof the frequencydistributioncurvesof left ventriculardimensionswas













50 yra,56%male),105of their unaffectedsiblingsand offepring,and 160
healthysubjectswithoutknownhypertensionand left ventricularhypartro-
phy(LVH)whowerefrequency-matchedto casesbyageandsex.Patienta
weredividedintofamilialand sporadicHCM(FHCM,n = 43 and SHCM,n
= 53).The regionof intereatin the angiotensinogengene(AGT),miaaense
mutationwithmethionine-to-threonineaminoacidsubstitutionat codon235
in angiotensinogen(T235M),waa amplifiedby PCRmethodwith the use
of allele-specificoligonucleotideprimersflankingthe polymorphicregionof
the AGTgeneto amplifytemplateDNA.TheT allelefrequencywashigher
in SHCMthanin unaffectedsiblingaandoffspring(66%vs 76%,p < 0.05)
andthan in healthysubjects(68Y0vs 77%,p c 0.05).The frequencyof T
alleleamongunaffectedsiblingsandoffspringwassimilarto that obaenfed
in healthysubjects(76%va77%).Theoddsratiowas2.1 (95Y0Cl 1.0-4.3,
X2= 4.0, p x 0.05)for SHCMpatients.Weconcludethat HCM,especially
in sporadiccaees,is partiallydeterminedbygeneticdisposition.Themolec-
ularvariantof angiotensinogenT235seemsto be a predisposingfactorfor
cardiachypertrophyin HCMandcarrieaan approximatelytwofoldincreased
risk.
